BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10503896)

  • 1. Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: relevance to risk assessment.
    Fukushima S
    Cancer Lett; 1999 Sep; 143(2):157-9. PubMed ID: 10503896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic administration of low doses of 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline on glutathione S-transferase placental form-positive foci development in the livers of rats fed a choline-deficient diet.
    Sone H; Wakabayashi K; Kushida H; Ochiai M; Sugimura T; Nagao M
    Jpn J Cancer Res; 1993 Aug; 84(8):859-64. PubMed ID: 8407550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3,8-dimethylimidazo [4,5-f ]quinoxaline (MeIQx) in rats.
    Ichihara T; Wanibuchi H; Totsuka Y; Morimura K; Wei M; Nakae D; Fukushima S
    Cancer Sci; 2004 Dec; 95(12):943-8. PubMed ID: 15596042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats.
    Murai T; Mori S; Kang JS; Morimura K; Wanibuchi H; Totsuka Y; Fukushima S
    Toxicol Pathol; 2008 Apr; 36(3):472-7. PubMed ID: 18413788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
    Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Takasuka N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
    Cancer Lett; 2003 Feb; 191(1):35-40. PubMed ID: 12609707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, at low dose levels.
    Kato T; Hasegawa R; Nakae D; Hirose M; Yaono M; Cui L; Kobayashi Y; Konishi Y; Ito N; Shirai T
    Jpn J Cancer Res; 1996 Feb; 87(2):127-33. PubMed ID: 8609060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury -- enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats.
    Iwai S; Karim R; Kitano M; Sukata T; Min W; Morimura K; Wanibuchi H; Seki S; Fukushima S
    Cancer Lett; 2002 May; 179(1):15-24. PubMed ID: 11880177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of 16-week dietary administration of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in rats].
    Kasahara K; Furukawa F; Nishikawa A; Tanakamaru Z; Kim HC; Ikezaki S; Takahashi M
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):107-11. PubMed ID: 9641823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats.
    Wei M; Hori TA; Ichihara T; Wanibuchi H; Morimura K; Kang JS; Puatanachokchai R; Fukushima S
    Cancer Lett; 2006 Jan; 231(2):304-8. PubMed ID: 16399231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of preneoplastic lesions by a low dose of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in the livers of rats treated with carbon tetrachloride.
    Sone H; Wakabayashi K; Kushida H; Sugimura T; Nagao M
    Carcinogenesis; 1992 May; 13(5):793-7. PubMed ID: 1586992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterocyclic amine mixture carcinogenesis and its enhancement by caffeine in F344 rats.
    Tsuda H; Sekine K; Uehara N; Takasuka N; Moore MA; Konno Y; Nakashita K; Degawa M
    Cancer Lett; 1999 Sep; 143(2):229-34. PubMed ID: 10503909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine.
    Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Uehara N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F; Wakabayashi K; Totsuka Y
    Jpn J Cancer Res; 2002 Oct; 93(10):1076-82. PubMed ID: 12417036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen.
    Hoshi M; Morimura K; Wanibuchi H; Wei M; Okochi E; Ushijima T; Takaoka K; Fukushima S
    Toxicol Sci; 2004 Oct; 81(2):273-9. PubMed ID: 15282409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement by cigarette smoke exposure of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis in close association with elevation of hepatic CYP1A2.
    Nishikawa A; Furukawa F; Miyauchi M; Son HY; Okazaki K; Koide A; Mori Y; Hirose M
    Jpn J Cancer Res; 2002 Jan; 93(1):24-31. PubMed ID: 11802804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of liver preneoplastic lesions by aminophenylnorharman, formed from norharman and aniline, in male F344 rats.
    Kawamori T; Totsuka Y; Ishihara J; Uchiya N; Sugimura T; Wakabayashi K
    Cancer Lett; 2001 Feb; 163(2):157-61. PubMed ID: 11165749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
    Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
    Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
    Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
    Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver.
    Mori Y; Koide A; Kobayashi Y; Furukawa F; Hirose M; Nishikawa A
    Mutagenesis; 2003 Jan; 18(1):87-93. PubMed ID: 12473741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration.
    Yamashita K; Adachi M; Kato S; Nakagama H; Ochiai M; Wakabayashi K; Sato S; Nagao M; Sugimura T
    Jpn J Cancer Res; 1990 May; 81(5):470-6. PubMed ID: 2116395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.